期刊文献+

中西医结合治疗糖尿病周围血管病变临床疗效观察 被引量:16

Clinical efficacy of combined Chinese and Western medicine in treating diabetic peripheral vascular disease
下载PDF
导出
摘要 [目的]观察中西医结合治疗糖尿病周围血管病变的临床疗效。[方法]将入选的糖尿病周围血管病变患者60例,随机分为治疗组30例和对照组30例,两组均常规治疗。治疗组给予复荣通脉胶囊口服及黄芪注射液静脉点滴联合西洛他唑口服,对照组单用西洛他唑片口服,观察两组临床症状、足背温度、踝肱动脉指数(ABI)的变化。[结果]治疗组在改善临床症状、足背温度、ABI等方面明显优于对照组(P<0.05,P<0.01),且未见明显不良反应。[结论]中西医结合治疗糖尿病周围血管病变,疗效优于单用西洛他唑组。 [Objective] To observe the clinical effect of combined treatment of traditional Chinese and Western medicine in treating diabetic peripheral vascular disease. [Methods] Sixty patients with diabetic peripheral vascular disease were randomly divided into treatment group and control group with 30 cases, two groups were treated with conventional therapy. Treatment group given Furong Tongmai capsule oral and astragalus injection intravenous combined with cilostazol oral, control group with single oral cilostazol tablets, observe two groups of clinical symptoms, temperatures in dorsal foot, ABI changes. [Results] In the treatment group, the improvement of clinical symptoms, the full back temperature, ABI and other aspects of the treatment group was significantly better than the control group(P〈0.05, P〈0.01), and no obvious adverse reactions. [Conclusion] Effect of combine traditional Chinese and Western medicine on diabetic peripheral vascular disease is better than the single use of cilostazol.
出处 《天津中医药大学学报》 CAS 2016年第2期92-94,共3页 Journal of Tianjin University of Traditional Chinese Medicine
基金 沧州市科技局课题项目(131302130)
关键词 糖尿病 周围血管病变 复荣通脉胶囊 西洛他唑 黄芪注射液 diabetes mellitus peripheral vascular disease Furong Tongmai capsule cilostazol astragalus injection
  • 相关文献

参考文献9

二级参考文献62

  • 1王本祥.现代中药药理学[M].天津:天津科学技术出版社,1999.941. 被引量:93
  • 2RONDINA M T, WEYR1CI-I A S. Targeting phosphodiesterases in anti - platelet therapy [ J ]. Handb Exp Pharmacol, 2012 ( 210 ) : 225 - 238. 被引量:1
  • 3SOUSA A G, SELVATICI L, KRIEGER J E, et al. Association between genetics of diabetes, coronary artery disease, and macro- vascular complications: exploring a common ground hypothesis [J]. Rev Diabet Stud, 2011, 8(2) : 230 -244. 被引量:1
  • 4SHEU J J, LINK C, TSAI C Y, et al. Combination of cilostazol and clopidogrel attenuates rat critical limb ischemia [ J ]. J Transl Med, 2012, 10(1) : 164. 被引量:1
  • 5MOHLER E R 3rd. Therapy insight: peripheral arterial disease and diabetes from pathogenesis to treatment guidelines [ J ]. Nat Clin Pract Cardiovasc Med, 2007, 4(3) : 151 -162. 被引量:1
  • 6JI X B, HOU M. Novel agents for anti - platelet therapy [ J ]. J Hematol Oncol, 2011,4: 44. 被引量:1
  • 7RHEESY, KIM Y S, CHON S, et al. Long-term effects of cilostazol on the prevention of macmvascular disease in patients with type 2 diabetes mellitus[ J]. Diabetes Res Clin Pract, 2011, 91(1): e11-e14. 被引量:1
  • 8ROBERTSON L, GHOURI M A, KOVACS F. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion follo- wing peripheral endovascular treatment [ J ]. Cochrane Database Syst Rev, 2012, 8: CD002071. 被引量:1
  • 9JANG J S, JIN H Y, SEO J S, et al. A meta - analysis of rando- mized controlled trials appraising the efficacy and safety of cilosta- zol after coronary artery stent implantation[ J]. Cardiology, 2012, 122(3) : 133 -134. 被引量:1
  • 10O'DONNELL M E, BADGER S A, SHARIF M A, et al. The vas- cular and biochemical effects of cilostazol in diabetic patients with peripheral arterial disease[J]. Vasc Endovascular Surg, 2009, 43 (2) : 132 -143. 被引量:1

共引文献607

同被引文献140

引证文献16

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部